Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer
ABSTRACT Background Oxaliplatin, a third‐generation platinum‐based chemotherapeutic agent, is widely used in the treatment of colorectal cancer (CRC). However, some patients do not respond effectively to oxaliplatin, and intrinsic resistance to the drug poses a significant challenge. Recent studies...
Saved in:
| Main Authors: | Reio Ueta, Hiroo Imai, Ken Saijo, Yoshifumi Kawamura, Shuto Kodera, Chikashi Ishioka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70940 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Citrobacter freundii Brain Abscess in a Preterm Infant: A Case Report and Literature Review
by: Nishad Plakkal, et al.
Published: (2013-04-01) -
Cathelicidin regulates goblet cell mucus secretion and mucus-associated proteins in Citrobacter rodentium-induced colitis
by: Niloofar Mirzadzare, et al.
Published: (2025-12-01) -
Epidemiology, phylogeny and genetic characterization of carbapenem-resistant Citrobacter spp. from 5 hospitals in China
by: Qiang Zhao, et al.
Published: (2025-05-01) -
Bioremediation Activity of Pb (II) Resistance Citrobacter sp. MKH2 Isolated from Heavy Metal Contaminated Sites in Iran
by: M. Mohseni
Published: (2014-06-01) -
Emerging trends of nosocomial Citrobacter species surgical wound infection: concern for infection control
by: B Thapa, et al.
Published: (2012-01-01)